Latest News and Press Releases
Want to stay updated on the latest news?
-
Oslo, Norway, 4 September, 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces that its partner and...
-
Kjetil Hestdal, President and Chief Executive Officer will present a Photocure company overview at the Pareto Securities' 6th Annual Health Care Seminar in Stockholm, on Friday, August 28, 2015 at...
-
Oslo, Norway, 19 August, 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies, announces today the appointment of BioSyent Pharma Inc. as their...
-
Oslo, Norway, 13 August 2015: Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused on photodynamic technologies, announces its results for the second quarter and the first half...
-
Oslo, Norway, 10 August, 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces today the approval of the Special...
-
This is a correction of the announcement from 13:12 06.08.2015. Reason for the correction: Corrected day for presentation to Thursday 13 August 2015. Photocure will present its second quarter and...
-
Photocure will present its second quarter and first half-year 2015 report on Wednesday 13 August 2015 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and...
-
Reference is made to the announcement on 12 May 2015 in respect of a capital increase of 32,164 new shares following exercise of employee share options in the company. The share capital increase has...
-
Oslo, Norway, 26 May 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces that its market maker agreement with...
-
Oslo, Norway, 22 May, 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces today the appointment of Juno...